Enzymotec Ltd
ENZY
ENZY was delisted on the 10th of January, 2018.
19 hedge funds and large institutions have $64.9M invested in Enzymotec Ltd in 2014 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 4 closing their positions.
14% more capital invested
Capital invested by funds: $57.1M → $64.9M (+$7.73M)
14% less funds holding
Funds holding: 22 → 19 (-3)
43% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 7
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$1.19M |
| 2 |
California Public Employees Retirement System
Sacramento,
California
|
+$1.12M |
| 3 |
Millennium Management
New York
|
+$98.4K |
| 4 |
Morgan Stanley
New York
|
+$66.8K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$436 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
D.E. Shaw & Co
New York
|
-$1.82M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$392K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$319K |
| 4 |
PC
Paulson & Co
New York
|
-$239K |
| 5 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$221K |
ENZY Hedge Fund Activity: Q4 2014 in Review
19 of the 3,765 institutional investors tracked by Wall St. Rank reported a position in Enzymotec Ltd (ENZY) for Q4 2014, worth a combined $64.9M — up 14% from $57.1M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of ENZY and 2 opened new positions — a net loss of 2 holders — while 7 trimmed existing stakes and 4 added.
The largest buyer was Fidelity Investments, adding an estimated $1.19M. The largest seller was D.E. Shaw & Co, cutting an estimated $1.82M.
- 19 institutional investors held Enzymotec Ltd (ENZY) as of Q4 2014, down from 22 in Q3 2014.
- Funds reported $64.9M of Enzymotec Ltd stock for Q4 2014, up 14% quarter-over-quarter.
- 2 funds opened new Enzymotec Ltd positions in Q4 2014 and 4 closed out, a net change of -2 holders.
- The largest Enzymotec Ltd buyer in Q4 2014 was Fidelity Investments, an estimated $1.19M added.
- The largest Enzymotec Ltd seller in Q4 2014 was D.E. Shaw & Co, an estimated $1.82M sold.
Based on aggregated 13F filings for Q4 2014.